Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinovac Given CFDA Go-Ahead for Trial of Chicken Pox Vaccine

publication date: Oct 26, 2015
Sinovac Biotech, a China vaccine maker, received approval from the CFDA to begin human clinical trials of its varicella (chicken pox) vaccine. The approval came 33 months after the CFDA accepted Sinovac's filing for the trial. Sinovac expects to complete testing the vaccine in 2017 and to market it in 2019. Ultimately, the company hopes to combine the varicella vaccine together with measles-mumps-rubella vaccines into a single product that protects against all four childhood diseases. More details....

Stock Symbol: (NSDQ: SVA)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital